<DOC>
	<DOCNO>NCT00391118</DOCNO>
	<brief_summary>Patients ovarian cancer usually get drug carboplatin paclitaxel initial treatment . In many patient tumor shrink , even disappear , treatment drug . But , unfortunately , tumor grow many patient . This trial try address question : Can delay time , till tumor grows , add 3rd drug standard therapy ? To answer question , patient , chance , either get experimental drug enzastaurin `` dummy pill '' ( placebo ) chemotherapy 3 year chemotherapy . Patients physician know , patient get enzastaurin placebo ( double-blinded trial ) . After predefined time , treatment uncovered , number patient tumor growth specific time point compare two treatment .</brief_summary>
	<brief_title>Comparing Two Treatments Ovarian Cancer : Standard Chemotherapy Plus Enzastaurin , Placebo ( `` Sugar Pill '' )</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Patients must specific stage disease , know FIGO stage IIB , IIC , III IV Organ function ( blood , renal , liver , cardiac ) must meet specific requirement . Patients , could become pregnant , must take care become pregnant study participation 6 month study discontinuation Patients must give write consent study participation . Patients receive experimental drug within last 30 day . Patients receive prior chemotherapy drug therapy current disease . Patients receive treatment cancer study participation . Patients unable discontinue concurrent administration carbamazepine , phenobarbital , phenytoin . Patients pregnant , breast feeding , use adequate contraceptive method prevent pregnancy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>